In vitro- undersøgelser tyder på, at CYP3A4 primært er ansvarlig for sitagliptins begrænsede metabolisme, og at CYP2C8 medvirker hertil.
In vitro studies indicated that the primary enzyme responsible for the limited metabolism of sitagliptin is CYP3A4, with contribution from CYP2C8.